Brent Cezairliyan is currently serving as the Vice President of Biology at Octagon Therapeutics since 2018. Prior to this role, Cezairliyan worked as a Research Fellow at Massachusetts General Hospital from 2008 to 2017. Cezairliyan holds a Sc.B. from Brown University and a Ph.D. from Massachusetts Institute of Technology.
Sign up to view 0 direct reports
Get started